lymphoid < lymphoma < lymphomas

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f KwdFr.f

List of bibliographic references indexed by lymphoma

Number of relevant bibliographic references: 18.

Ident.	Authors (with country if any)	Title
000194 (2019)	Chunsun Jiang [États-Unis] ; Chengfeng Bi [États-Unis] ; Xiaoxing Jiang [États-Unis] ; Tian Tian [États-Unis] ; Xin Huang [États-Unis] ; Cheng Wang [États-Unis] ; Mario R. Fernandez [États-Unis] ; Javeed Iqbal [États-Unis] ; Wing C. Chan [États-Unis] ; Timothy W. Mckeithan [États-Unis] ; Robert E. Lewis [États-Unis] ; Kai Fu [États-Unis]	The miR-17~92 cluster activates mTORC1 in mantle cell lymphoma by targeting multiple regulators in the STK11/AMPK/TSC/mTOR pathway.
000211 (2019)	Carolina Caro-Vegas [États-Unis] ; Aubrey Bailey [États-Unis] ; Rachele Bigi [États-Unis] ; Blossom Damania [États-Unis] ; Dirk P. Dittmer [États-Unis]	Targeting mTOR with MLN0128 Overcomes Rapamycin and Chemoresistant Primary Effusion Lymphoma.
000245 (2019)	Claudio Scuoppo [États-Unis] ; Jiguang Wang [États-Unis] ; Mirjana Persaud [États-Unis] ; Sandeep K. Mittan [États-Unis] ; Katia Basso [États-Unis] ; Laura Pasqualucci [États-Unis] ; Raul Rabadan [États-Unis] ; Giorgio Inghirami [États-Unis] ; Carla Grandori [États-Unis] ; Francesc Bosch [États-Unis, Espagne] ; Riccardo Dalla-Favera [États-Unis]	Repurposing dasatinib for diffuse large B cell lymphoma.
000794 (2017)	Suchitra Mohanty [Inde] ; Amit Kumar [Inde] ; Piyanki Das [Inde] ; Sushil Kumar Sahu [Inde] ; Tathagata Choudhuri [Inde]	Multi-targeted therapy of everolimus in Kaposi's sarcoma associated herpes virus infected primary effusion lymphoma.
000D08 (2015)	Penny Anders ; Prasanna M. Bhende ; Michael Foote ; Dirk P. Dittmer ; Steven I. Park ; Blossom Damania	Dual inhibition of phosphatidylinositol 3-kinase/mammalian target of rapamycin and mitogen activated protein kinase pathways in non-Hodgkin lymphoma.
000D75 (2014)	Jun-Ichi Kawada [Japon] ; Yoshinori Ito [Japon] ; Seiko Iwata [Japon] ; Michio Suzuki [Japon] ; Yoshihiko Kawano [Japon] ; Tetsuhiro Kanazawa [Japon] ; Mohammed Nure Alam Siddiquey [Japon] ; Hiroshi Kimura [Japon]	mTOR inhibitors induce cell-cycle arrest and inhibit tumor growth in Epstein-Barr virus-associated T and natural killer cell lymphoma cells.
000F14 (2014)	Eylem Akar Zkan [Turquie] ; B Handan Özdemir ; Ayd Ncan Akdur ; E Ebru Deniz ; Mehmet Haberal	Burkitt lymphoma after transplant: an aggressive lymphoproliferative disease.
001270 (2011)	Osman Cen [États-Unis] ; Richard Longnecker	Rapamycin reverses splenomegaly and inhibits tumor development in a transgenic model of Epstein-Barr virus-related Burkitt's lymphoma.
001323 (2011)	Sarah E. Gibson [États-Unis] ; Steven H. Swerdlow ; Fiona E. Craig ; Urvashi Surti ; James R. Cook ; Michael A. Nalesnik ; Chris Lowe ; Katrina M. Wood ; Chris M. Bacon	EBV-positive extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in the posttransplant setting: a distinct type of posttransplant lymphoproliferative disorder?
001369 (2010)	E. Régnier-Rosencher [France] ; B. Barrou ; A-G Marcelin ; C. Jacobzone-Leveque ; J. Cadranel ; V. Leblond ; C. Francès	[Primary effusion lymphoma in two kidney transplant recipients].
001626 (2008)	E. Boulanger [France] ; P V Afonso ; Y. Yahiaoui ; H. Adle-Biassette ; J. Gabarre ; F. Agbalika	Human herpesvirus-8 (HHV-8)-associated primary effusion lymphoma in two renal transplant recipients receiving rapamycin.
001640 (2008)	Kenneth G. Lucas [États-Unis] ; David Ungar ; Melanie Comito ; Brandt Groh	Epstein Barr virus induced lymphoma in a child with IPEX syndrome.
001653 (2008)	Susan Li Er Loong [Singapour] ; Jacqueline Siok Gek Hwang ; Soon-Thye Lim ; Swee Peng Yap ; Miriam Tao ; Tsung-Wen Chong ; Leonard Hwan Cheong Tan ; Hung Huynh	An Epstein-Barr virus positive natural killer lymphoma xenograft derived for drug testing.
001700 (2007)	Sang-Hoon Sin [États-Unis] ; Debasmita Roy ; Ling Wang ; Michelle R. Staudt ; Farnaz D. Fakhari ; Dhavalkumar D. Patel ; David Henry ; William J. Harrington ; Blossom A. Damania ; Dirk P. Dittmer	Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling.
001734 (2007)	N. Mohsin [Oman] ; M. Budruddin ; P. Kamble ; M. Khalil ; A. Pakkyarra ; A. Jha ; E. Mohammed ; H. Ahmed ; J. Ahmed ; S. Thomas ; J M Campistol ; A. Daar	Complete regression of cutaneous B-cell lymphoma in a renal transplant patient after conversion from cyclosporin to sirolimus.
001737 (2007)	James E. Talmadge [États-Unis]	American Society of Hematology--48th Annual Meeting and Exposition. Treatments for leukemia and lymphoma. 9-12 December 2006 Orlando, FL, USA.
001A58 (1999)	Q. Zhang [États-Unis] ; B. Lee ; M. Korecka ; G. Li ; C. Weyland ; S. Eck ; A. Gessain ; N. Arima ; S R Lessin ; L M Shaw ; S. Luger ; M. Kamoun ; M A Wasik	Differences in phosphorylation of the IL-2R associated JAK/STAT proteins between HTLV-I(+), IL-2-independent and IL-2-dependent cell lines and uncultured leukemic cells from patients with adult T-cell lymphoma/leukemia.
001B13 (1995)	S. Muthukkumar [États-Unis] ; T M Ramesh ; S. Bondada	Rapamycin, a potent immunosuppressive drug, causes programmed cell death in B lymphoma cells.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "lymphoma" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "lymphoma" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    RapamycinFungusV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    lymphoma
}}

---

This area was generated with Dilib version V0.6.38. Data generation: Thu Nov 19 21:55:41 2020. Site generation: Thu Nov 19 22:00:39 2020